Modified Herbst Approach to Improve Chin Projection
Launched by UNIVERSITY OF ALBERTA · Oct 24, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to improve the alignment of teeth and the appearance of the chin for people with a specific dental condition called Class II malocclusion. One approach uses a device called a bite corrector before placing braces, while the other adds small bone screws to support the bite corrector before braces are put on. The goal is to find out which method leads to better changes in the face, teeth, and bones after treatment and to understand how comfortable participants feel using these devices.
To be eligible for this trial, participants should have a certain level of Class II malocclusion, a specific dental relationship between their back teeth, and should be in the early stage of their permanent teeth coming in. They should not have any missing teeth from birth. If you join the study, you will be asked about your experiences with the devices used during treatment. This research is currently recruiting participants of all genders aged between 14 and 18 years, so it could be a good opportunity for those looking for a solution to their dental concerns.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Class II skeletal malocclusion based on PgOLp more than 85 mm and A-OLp more than 75 mm.
- • Perceived potential improvement of facial convexity.
- • At least end-to-end bilateral molar relationship.
- • Early permanent dentition.
- • No congenitally missing teeth.
- Exclusion criteria:
- • Class II skeletal malocclusion based on PgOLp less than 85 mm and A-OLp less than 75 mm.
- • Only reasonable management option is surgery.
- • Less than an end-to-end bilateral molar relationship.
- • Mixed dentition dentition.
- • Congenitally missing teeth.
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Carlos Flores Mir, DSc
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials